HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

515.560

-16.828-3.16%

Number of Gainers:6

Number of Losers:26

Number of Flat:1

PE:- -

High:526.804

Open:526.804

Low:504.120

Close:532.388

Volume:37.26M

Turnover:983.79M

Market Cap:325.98B

Float Cap:291.58B

Loading ...

Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?

Zai Lab to Present First Global Data on DLL3 ADC Zocilurtatug Pelitecan in First-Line ES-SCLC Trial at ESMO 2026

Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (Es-Sclc)

THOMSON REUTERS

EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29

China's BioDlink International HY Revenue Falls

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Biodlink International Co H1 Revenue RMB 246.011 Million

THOMSON REUTERS

ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29

Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals

AH Premium Statistics for September 29

China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets

CStone Pharma-B (02616) Jumps Nearly 7% as ESMO Data Update Nears and Executive's Continued Share Purchases Signal Confidence in Growth

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

Ascletis Pharma Reports Positive Results From ASC50 Psoriasis Trial

MT Newswires Live

GENFLEET-B (02595) Shares Surge Nearly 8% in Early Trading; Investigational Oral Drug Proposed for Breakthrough Therapy Designation

InnoCare Pharma Jumps Over 5% Intraday After Signing R&D Collaboration and License Agreement with Eli Lilly

China A-Share Indices Reverse Early Gains as Real Estate Stocks Surge, Vanke Hits Limit Up, Biotech Rallies, Hang Seng Tech Falls Over 1%, New Energy Vehicle Shares Decline

Hong Kong Stocks Open: Hang Seng Index Turns Lower After Flat Start; Pharma Shares Defy Trend as AKESO Surges Nearly 10%

Estimating the Value of PL-5: How Much Is This Wound Infection Candidate Worth for HK-Listed Aspirant Prolytix?

Prairie Pharmaceutical's Second Attempt at HKEX Listing: Cash Crunch, Billion-Yuan Redemption Liability Looming, Core Product Commercialization Faces Multiple Hurdles

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BK1574/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":515.5602,"timestamp":1790928487328,"preClose":532.3884,"halted":0,"volume":37258611,"delay":0,"changeRate":-0.031609,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-16.828247,"latestTime":"10-02 16:00:00","open":526.80365,"high":526.80365,"low":504.12042,"amount":983786061.5,"amplitude":0.042607,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"pbRate":3.967371,"peRate":176.437057,"turnoverRate":0.001378,"increases":5,"decrements":27,"flats":0,"marketCap":325975381968,"floatMarketCap":291576058040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":526.80365,"amplitude":0.042607,"preClose":532.3884,"low":504.12042,"pbRate":"3.967371","latestPrice":515.5602,"volume":37258611,"delay":0,"open":526.80365,"prevYearClose":556.26263,"prevWeekClose":495.27,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":495.278,"twentyDayClose":515.473,"sixtyDayClose":490.453,"secType":"PLATE","market":"HK","turnoverRate":0.001378,"peRate":176.437057,"marketCap":325975381968,"floatMarketCap":291576058040,"timestamp":1790928487328,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":26,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1110462263","title":"Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?","url":"https://stock-news.laohu8.com/highlight/detail?id=1110462263","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110462263?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680230,"startTime":"0","endTime":"0","summary":"Positive developments across policy, industry, pharmaceutical companies, AIDD, and corporate performance are resonating together.Is innovative drugs still the key theme to watch in the fourth...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","06978","BK1574","LNGR","159992","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215090","title":"Zai Lab to Present First Global Data on DLL3 ADC Zocilurtatug Pelitecan in First-Line ES-SCLC Trial at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215090","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215090?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679688,"startTime":"0","endTime":"0","summary":"Zai Lab to present first global data on DLL3 ADC zocilurtatug pelitecan in first-line ES-SCLC trial at ESMO 2026Zai Lab flagged first global results from a trial of zocilurtatug pelitecan for first-li","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8p8mnn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09688","BK1588","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671721575","title":"Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (Es-Sclc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671721575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671721575?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA6R3CVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09688","BK1588","BK1574","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121622936","title":"EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1121622936","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121622936?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679009,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on September 29, 2026, the company spent HK$1.6999 million to repurchase 1 million shares, at a repurchase price of HK$1.695 to HK$1.7 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06998","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671229065","title":"China's BioDlink International HY Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2671229065","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671229065?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674167,"startTime":"0","endTime":"0","summary":"China's BioDlink International HY revenue fallsOverviewChina CDMO provider's half-year revenue fell to RMB 246 blnCompany expanded CDMO operations and invested in R&D during the reporting periodWuXi X","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL1N45L09P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01875","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101970069","title":"Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus","url":"https://stock-news.laohu8.com/highlight/detail?id=1101970069","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101970069?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674165,"startTime":"0","endTime":"0","summary":"Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688389","BK1574","BK1583","BK0251","GDOC","HART","LGHT","LNGR","MEDX","PTH","RSPH","AGNG","IEIH","159883","09996","BK1100","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671029702","title":"Biodlink International Co H1 Revenue RMB 246.011 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2671029702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671029702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:18","pubTimestamp":1790673528,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nPLXMLCG4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01875","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111891998","title":"ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1111891998","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111891998?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:58","pubTimestamp":1790672320,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 29, 2026, the company spent HK$1.1383 million to repurchase 53,000 shares, with a repurchase price ranging from HK$21.36 to HK$21.54 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113675289","title":"Hong Kong Stocks Slip as Property and Biotech ETF Sectors Rally on Policy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1113675289","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113675289?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:43","pubTimestamp":1790671392,"startTime":"0","endTime":"0","summary":"Hong Kong's three major indices closed slightly lower today, with heavyweight technology stocks weakening and structural divergence across the board standing out, while mainland property and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","FDN","BK1161","06978","LNGR","MEDX","IBBQ","159992","BK4585","BK4550","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140639624","title":"AH Premium Statistics for September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1140639624","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140639624?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:21","pubTimestamp":1790670095,"startTime":"0","endTime":"0","summary":"As of the market close on September 29, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) ranked as the top three stocks by AH premium rate, with premium rates of 1155.81%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","BK1116","01108","LU0593848301.USD","LU0918141705.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","02218","02846","IE00BMCWC346.EUR","IE0008368742.USD","LU0067412154.USD","00991","IE00BGHQDM52.EUR","LU0797268264.HKD","BK1546","LU0149721374.USD","BK1507","BK1190","03328","01057","LU0052750758.USD","IE00B543WZ88.USD","LU2226246903.HKD","LU2097828805.USD","LU0516422440.USD","LU2097828714.EUR","HK0000352382.USD","BK1521","IE00BZ08YR35.GBP","LU0823426308.USD","BK1515","LU0431992006.USD","LU0672654166.SGD","BK1125","BK1141","BK1539","00568","BK1530","01033","LU0348805143.USD","LU1224709979.USD","LU1211504680.USD","IE0034224299.USD","LU0320764599.SGD","LU0048580855.USD","LU2097828557.USD","HK0001040168.HKD","LU0327786744.USD","LU0823426480.USD","BK1144","LU2097828474.EUR","LU0329678337.USD","LU0417516902.SGD","LU1282649141.HKD","00811","LU1960683339.HKD","LU1366334578.USD","02338","IE0008369823.USD","LU0417516738.SGD","BK1522","LU0106959298.USD","LU0648948544.HKD","LU2476274308.USD","BK1122","LU2294711473.HKD","06951","BK1237","LU0348814723.USD","LU0348788117.USD","BK1544","03200","LU0531970944.HKD","LU0821914370.USD","LU0307460666.USD","BK1191","BK1554","LU0128522157.USD","LU0329678170.USD","LU1675838814.USD","LU1115378108.SGD","BK1183","LU0828237510.HKD","LU0228659784.USD","IE00B031HY20.USD","BK1562","SG9999011746.SGD","02359","BK1583","LU0049853897.USD","BK1202","LU0348825331.USD","BK1193","03968","HK0000306701.USD","BK1170","LU0456827905.SGD","83188","LU1255011170.USD","LU1282649067.USD","LU0082770016.SGD","LU0266512127.USD","01812","SG9999001226.SGD","06185","LU1282648689.USD","LU0516423174.USD","82843","LU0561508036.HKD","LU0516422366.SGD","LU1481107354.HKD","02899","LU1366334651.USD","LU1282649810.SGD","82846","HK0000306685.HKD","LU0039217434.USD","LU1504937902.USD","LU0117841782.USD","LU0455707207.USD","LU0463099449.HKD","159982","LU3063872942.SGD","06127","IE00B3M56506.USD","HK0001040143.USD","LU1303224171.USD","LU1988902786.USD","LU0886674414.USD","LU2242644610.SGD","03986","LU0061477393.USD","LU1048596156.SGD","BK1223","SG9999006597.SGD","LU0708995583.HKD","LU0181495838.USD","LU1831875114.USD","LU0043850808.USD","BK1249","LU0214875030.USD","LU1807302812.USD","LU2097828631.EUR","LU0348816934.USD","BK1171","LU0918141887.USD","LU0328353924.USD","02238","LU2045819591.USD","LU0320764755.SGD","LU1244550577.SGD","SG9999004220.SGD","LU0634319403.HKD","BK1119","00042","03750","LU0228367735.SGD","SG9999002463.SGD","02691","LU2177674079.SGD","LU0140636845.USD","07233","LU0266512473.USD","LU0589944569.HKD","02865","BK1594","LU0384037296.USD","LU1152091754.HKD","LU0229945570.USD","BK1147","LU0345780521.USD","LU0348735423.USD","LU1769817179.HKD","IE00BF5LJ272.USD","LU0531971595.HKD","BK1533","LU0359201885.HKD","LU0348766576.USD","LU0449509016.USD","LU1064131342.USD","LU0051755006.USD","03308","LU0173614495.USD","LU2039709279.SGD","LU0359201612.USD","03143","LU0149534421.HKD","LU0588546209.SGD","02827","09976","03188","00553","LU1244550221.USD","LU1688375341.USD","IE00B031J352.USD","LU0572944931.SGD","LU2778985437.USD","LU0359202008.SGD","LU0348767384.USD","LU1328277881.USD","LU1023057109.AUD","LU0326950275.SGD","LU0502904849.HKD","LU0029875118.USD","LU0287142896.SGD","BK1149","LU1251922891.USD","BK1198","EWH","HK0000352291.HKD","82823","LU1961090484.USD","LU0890818403.SGD","LU1655091616.SGD","IE0032431581.USD","BK1231","LU1880383440.USD","LU0607220059.USD","LU0543330566.HKD","BK1574","02823","02822","LU1188198961.HKD","LU1242518857.USD","LU0868486357.SGD","LU1226287529.USD","LU0211977185.USD","06067","BK1163","LU0231483743.USD","LU0862451753.SGD","02843","LU1046422090.SGD","LU0164939612.USD","LU0314109678.HKD","LU0082770016.USD","BK1560","BK1181","LU0516423091.SGD","SG9999002828.SGD","LU0164880469.USD","LU2476274720.SGD","02701","LU0540923850.HKD","LU0979878070.USD","IE00BZ08YT58.USD","LU1770034418.SGD","LU0488056044.USD","06821","BK1505","LU0164865239.USD","LU2264538146.SGD","BK1105","BK1130","LU1206782309.USD","LU0737861699.HKD","BK1514","LU1008478684.HKD","LU0106252389.USD","IE00B5MMRT66.SGD","03996","LU0345780281.USD","LU0791590937.USD","LU0163747925.USD","LU0501845795.SGD","BK1551","LU1880383366.USD","LU0269904917.USD","LU0871576103.HKD","82822","LU0348827113.USD","01349","HK0000320223.HKD","IE00BYV24P56.USD","LU0456854461.SGD","LU1242518931.SGD","BK1110","IE00BVYPNQ40.USD","03228","LU1993786604.SGD","LU0828238088.HKD","LU0509642566.USD","LU2008162690.USD","83130","BK1576","03130","LU1794554557.SGD","LU2399975544.HKD","LU0737861772.HKD","LU1152091168.USD","LU0254981946.USD","SG9999014674.SGD","03678","LU2125910500.SGD","LU1719994722.HKD","BK1592","LU0543330483.HKD","LU1105468828.SGD","IE0031814852.USD","LU0469268626.HKD","LU0828237940.HKD","LU0315179316.USD","IE00BVYPNP33.GBP","LU0516422952.EUR","LU1813983027.USD","LU0370786039.SGD","BK1161","LU0244354667.USD","399300","LU1808992512.USD","00187","LU1769817096.USD","02475","SG9999001093.SGD","LU0165289439.USD","LU0880133367.SGD","LU0456846285.SGD","LU0640798160.USD","BK1564","LU0791591158.USD","LU0096374516.USD","LU1244550494.USD","LU1720050803.USD","HK0000320264.USD","LU0210526637.USD","LU0620787316.HKD","BK1148","IE00B29SXG58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113085280","title":"China Innovation Drug ETF (03525) Rises Over 2%, Focusing on R&D-Driven Quality Innovative Drug Companies in Hong Kong and Developed Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1113085280","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113085280?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:22","pubTimestamp":1790666534,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, China Innovation Drug ETF (03525) rose over 2%, reaching 2% as of press time, at HK$10.2, with a turnover of HK$491,300.It is reported that the China Innovation Drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","03525","BK4550","IBBQ","BK4588","MEDX","BK4585","159992","WSGE","FDN","BK1161","BK1574","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172233611","title":"CStone Pharma-B (02616) Jumps Nearly 7% as ESMO Data Update Nears and Executive's Continued Share Purchases Signal Confidence in Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1172233611","media":"Stock News","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172233611?lang=en_us&edition=fundamental","pubTime":"2026-09-29 14:10","pubTimestamp":1790662217,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, CStone Pharma-B (HKEX: 02616) rose nearly 7%, up 6.81% as of press time to HK$5.49, with turnover of HK$35.1891 million.On the news front, the latest clinical data...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","KCAI","VXUS","BK4585","BK4588","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1587","BK1161","02162","IBBQ","BK1583","MEDX","BK1574","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671293640","title":"Ascletis Pharma Reports Positive Results From ASC50 Psoriasis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671293640","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671293640?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:39","pubTimestamp":1790660392,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said its oral small-molecule IL-17A inhibitor ASC50 showed positive results in a 28-day proof-of-concept clinical trial in the U.S. for patients with mild-to-moderate plaque psoriasis, according to a Tuesday filing with the Hong Kong bourse.The once-daily 200 mg treatment achieved a 48.9% placebo-adjusted reduction in psoriasis area and severity index, or PASI, score after 28 days.The reduction increased to 60.7% six days after the final dose and 65.9% 15 days after the final dose, the filing said.The treatment was safe and well tolerated, with all adverse events reported as mild and transient.Shares of the pharmaceutical firm were down nearly 2% in Tuesday morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156162380","title":"GENFLEET-B (02595) Shares Surge Nearly 8% in Early Trading; Investigational Oral Drug Proposed for Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1156162380","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156162380?lang=en_us&edition=fundamental","pubTime":"2026-09-29 11:31","pubTimestamp":1790652676,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) climbed nearly 8% in morning trading. As of press time, the stock was up 5.47% at HK$28.9, with turnover of HK$37.7862 million.On the news front, the company's self-developed oral...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","VXUS","BK4588","159938","02595","KCAI","BK4585","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152948849","title":"InnoCare Pharma Jumps Over 5% Intraday After Signing R&D Collaboration and License Agreement with Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=1152948849","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152948849?lang=en_us&edition=fundamental","pubTime":"2026-09-29 11:00","pubTimestamp":1790650823,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (09969) saw its intraday gain exceed 5%. As of press time, the stock was up 2.62% at HK$14.47, with a turnover of HK$42.1518 million.InnoCare Pharma recently announced that it has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688428","09969","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183825958","title":"China A-Share Indices Reverse Early Gains as Real Estate Stocks Surge, Vanke Hits Limit Up, Biotech Rallies, Hang Seng Tech Falls Over 1%, New Energy Vehicle Shares Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1183825958","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183825958?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:34","pubTimestamp":1790649241,"startTime":"0","endTime":"0","summary":"On September 29, A-share markets traded lower in morning session, with the three major indices collectively reversing early gains after an initial rally. The micro-cap stock index rebounded, the real...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02202","LU0348827113.USD","LU0072913022.USD","LU0708995583.HKD","EVS.SI","BK0278","LU1993786604.SGD","NIO.SI","BK0201","LU2399975544.HKD","BK4504","03417","BK1574","BK4548","07552","03067","IE00B5MMRT66.SGD","BK4534","LU1961090484.USD","IE00B543WZ88.USD","LU0320764599.SGD","BK0183","LU0348735423.USD","LU1655091616.SGD","LU1226287529.USD","000002","LU0561508036.HKD","LU0348783233.USD","IE00B0JY6N72.USD","BK4532","LU0348825331.USD","03032","HSTECH","LU1720050803.USD","03033","BK0188","BK1161","BK0028","LU2476274720.SGD","09866","LU2778985437.USD","BK4526","LU2148510915.USD","BK0086","BK4505","BK0157","LU0348767384.USD","BK4588","BK0196","LU1580142542.USD","LU0501845795.SGD","BK0180","HSI","LU0348784397.USD","BK4531","LU2476274308.USD","03088","LU0067412154.USD","LU1064131003.USD","07226","LU1328615791.USD","IE00BPRC5H50.USD","HTImain","BK0273","LU0052750758.USD","000001","02837","09088","03423","BK4585","LU0417516571.SGD","LU1781817850.SGD","NIO","LU0417516902.SGD","LU0634319403.HKD","BK0178","LU1807302812.USD","BK4581","LU0417516738.SGD","BK0174","09067","LU0880133367.SGD","BK4099","BK4574","LU0348766576.USD","LU2488822045.USD","09926","LU0540923850.HKD","NIOG","LU1064130708.USD","BK0012","BK4555","BK4509","KURE","LU1794554557.SGD","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144350622","title":"Hong Kong Stocks Open: Hang Seng Index Turns Lower After Flat Start; Pharma Shares Defy Trend as AKESO Surges Nearly 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144350622","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144350622?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:04","pubTimestamp":1790647446,"startTime":"0","endTime":"0","summary":"On September 29, Hong Kong's three major indices opened mixed before collectively turning lower.The Hang Seng Index opened up 0.02% at 24,648.64 points, and was last down 0.59% at 24,496.54 points....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02837","09067","MCHmain","BK1574","KURE","LU0417516902.SGD","LU0417516738.SGD","07300","HSI","LU0348827113.USD","02828","LU2778985437.USD","07200","LU2476274308.USD","HSTECH","LU0561508036.HKD","03088","LU0417516571.SGD","02833","07552","LU1794554557.SGD","03423","03417","BK1161","HSCEI","02802","07588","82800","LU0348766576.USD","LU0540923850.HKD","83115","LU0348767384.USD","LU0348784397.USD","IE00B5MMRT66.SGD","513600","09926","IE00B543WZ88.USD","LU0348825331.USD","LU2476274720.SGD","82828","03032","02800","03419","HHImain","LU0348783233.USD","IE00BPRC5H50.USD","07226","LU1961090484.USD","03067","03033","07288","03037","09088","HTImain","09115","03115","LU2399975544.HKD","03416","LU1720050803.USD","HSImain","LU2488822045.USD","LU0634319403.HKD","07500","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181831156","title":"Estimating the Value of PL-5: How Much Is This Wound Infection Candidate Worth for HK-Listed Aspirant Prolytix?","url":"https://stock-news.laohu8.com/highlight/detail?id=1181831156","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181831156?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:41","pubTimestamp":1790646095,"startTime":"0","endTime":"0","summary":"Recently, Prolytix filed for a Hong Kong listing for the second time. The company's core innovative drug, pramlintide sodium spray (PL-5), has received marketing approval from the National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1574","09939","IPOS","159938","BK4585","BK1515","BK1161","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130832239","title":"Prairie Pharmaceutical's Second Attempt at HKEX Listing: Cash Crunch, Billion-Yuan Redemption Liability Looming, Core Product Commercialization Faces Multiple Hurdles","url":"https://stock-news.laohu8.com/highlight/detail?id=1130832239","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130832239?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:41","pubTimestamp":1790646076,"startTime":"0","endTime":"0","summary":"Recently, Prairie Pharmaceutical submitted its second main board listing application to the Hong Kong Stock Exchange, seeking to list under Chapter 18A rules. Just three months earlier, the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","09939","BK1574","BK1515","HEXmain"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}